Artificial intelligence (AI) and machine learning (ML) present unique ethical, security, and technical considerations. Insights gained by the development of high-quality medical devices that use...
Read The ArticleOn October 7th, a ClinicalTrials.gov webinar provided an update on modernization efforts and information on the anticipated launch of beta ClinicalTrials.gov. You can now find...
Read The Article“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,...
Read The ArticleOLAW recently released two notices to clarify the requirement for NIH grant to protocol congruence review (NOT-OD-22-005) and contract to protocol congruence review (NOT-OD-22-006). These...
Read The ArticleThe revised Common Rule identifies certain public health surveillance activities, “including the collection and testing of information or biospecimens, conducted, supported, requested, ordered, required, or...
Read The Article“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,...
Read The ArticleCITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for...
Read The ArticleIt’s Finally Here On October 6, 2021, the International Council on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) announced that...
Read The Article“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,...
Read The ArticleCurrently, it is notoriously difficult to for researchers to conduct clinical research using marijuana, despite the fact that 18 states and Washington, D.C. have legalized...
Read The Article
